Abbott Laboratories (ABT) director receives 382 stock equivalent units as fees

Rhea-AI Filing Summary

ABBOTT LABORATORIES director John G. Stratton received a grant of 382 stock equivalent units as board compensation. The units were credited on the basis of a reference price of $102.67 per unit and are held in a stock equivalent unit account under a grantor trust established by the director.

The stock equivalent units are paid in cash, generally at age 65 or upon retirement from the board, and earn the same return as if the fees were invested in Abbott common shares, including a dividend reinvestment feature. Following this award, Stratton’s balance in the account totals 13,489 stock equivalent units. This is a non‑market, compensation-related acquisition rather than an open-market share purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Stratton John G

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Equivalent Units	382	$102.67	$39K

Holdings After Transaction: Stock Equivalent Units — 13,489 shares (Direct)

Footnotes (1)

1. Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares. Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Key Figures

Stock equivalent units granted: 382 units Reference price per unit: $102.67 per unit Total units after transaction: 13,489 units +1 more

4 metrics

Stock equivalent units granted 382 units Director fees credited as of 2026-03-31

Reference price per unit $102.67 per unit Used to credit director fees into units

Total units after transaction 13,489 units Stock equivalent unit balance after grant

Conversion or exercise price $0.00 Stock equivalent units, cash-settled compensation

Key Terms

Stock Equivalent Units, grantor trust, dividend reinvestment feature

3 terms

Stock Equivalent Units financial

"Director fees credited to a stock equivalent unit account under a grantor trust"

Stock equivalent units are financial claims or instruments that are treated as if they were actual shares for purposes like calculating ownership, dilution, and earnings per share. Think of them as promises or placeholders for future slices of company pie—options, restricted units, or convertible securities—that don’t yet sit on the table but will reduce each existing slice when converted. Investors track them because they change how much of a company each share really represents and can affect valuation and voting power.

grantor trust financial

"under a grantor trust established by the director and paid, in cash, generally at age 65"

A grantor trust is a legal arrangement where the person who puts assets into the trust keeps enough control or rights that, for tax and legal purposes, those assets are treated as still belonging to that person. For investors, that matters because income, gains and losses generated by the trust typically flow through to the grantor (or directly to investors) for tax reporting and distributions, affecting after-tax returns and cash flow predictability — think of it like a mailbox that forwards all the mail back to the sender rather than holding it inside.

dividend reinvestment feature financial

"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Stratton John G

(Last) (First) (Middle)

100 ABBOTT PARK ROAD

(Street)

ABBOTT PARK ILLINOIS 60064

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES [ ABT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Equivalent Units	(1)	03/31/2026		A		382		(1)	(1)	Common Shares	382	$102.67	13,489(2)	D

Explanation of Responses:

1. Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

2. Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

	/s/ John G. Stratton by Jessica H. Paik, Attorney-in-Fact	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did ABBOTT LABORATORIES (ABT) director John G. Stratton report?

John G. Stratton reported receiving 382 stock equivalent units as board compensation. These units are credited to a stock equivalent unit account and mirror Abbott share performance, including dividends, but are ultimately settled in cash rather than through delivery of common shares.

Was the ABBOTT LABORATORIES (ABT) Form 4 a market purchase or sale?

No, the filing reflects a compensation grant, not a market trade. Stratton received 382 stock equivalent units as director fees, credited to a stock equivalent unit account, so there was no open-market buying or selling of Abbott common shares in this transaction.

How many stock equivalent units does ABBOTT LABORATORIES (ABT) director Stratton hold after this grant?

After the award, Stratton’s stock equivalent unit balance is 13,489 units. These units track the return of Abbott common shares and dividends, but they are paid out in cash, generally at age 65 or upon retirement from the company’s board.

How do ABBOTT LABORATORIES (ABT) stock equivalent units work for directors?

Director fees can be credited as stock equivalent units into a grantor trust account. These units earn the same return as Abbott shares, including dividend reinvestment, but are ultimately paid in cash, typically at age 65 or upon retirement from the board rather than in stock.

What reference price was used for Stratton’s ABBOTT LABORATORIES (ABT) stock equivalent units?

The 382 stock equivalent units were credited using a reference price of $102.67 per unit. This price helps determine how many units are credited for the director’s fees, aligning the unit value with Abbott’s share price performance for compensation tracking purposes.